Valuation: Stryker Corporation

Market Cap 129B 112B 105B 95.91B 180B 12,318B 183B 1,227B 481B 6,174B 486B 475B 20,411B P/E 2026 *
26.2x
P/E 2027 * 22.8x
Enterprise Value 139B 120B 112B 103B 193B 13,186B 196B 1,313B 515B 6,609B 520B 509B 21,850B EV / Sales 2026 *
5.08x
EV / Sales 2027 * 4.56x
Free-Float
94.9%
Yield 2026 *
1.07%
Yield 2027 * 1.14%
1 day+0.12%
1 week+3.95%
Current month+3.95%
1 month+2.10%
3 months+15.90%
6 months-1.81%
Current year-2.08%
1 week 284.9
Extreme 284.9
298
1 month 268.4
Extreme 268.4
308.3
Current year 239.1
Extreme 239.1
332.4
1 year 239.1
Extreme 239.1
340.3
3 years 239.1
Extreme 239.1
340.3
5 years 182.32
Extreme 182.32
340.3
10 years 97.9
Extreme 97.9
340.3
Manager TitleAgeSince
Chief Executive Officer 60 01/10/2012
Director of Finance/CFO 50 01/04/2025
President 49 01/01/2026
Director TitleAgeSince
Director/Board Member 82 01/01/1974
Director/Board Member 71 01/01/1984
Chairman 60 22/07/2014
Change 5-day change 1-year change 3-year change Capi.($)
+0.07%+3.95% - - 129B
+0.21%+3.81%-10.16%+18.11% 129B
+1.37%-3.93%-17.22%-0.67% 12.43B
+4.20%+7.23%+103.16%+137.80% 10.08B
+2.59%-2.36%-42.76%-68.89% 4.58B
+2.93%+0.77%-14.62%+40.45% 2.62B
+1.41%+18.44%-22.82%-77.60% 1.7B
+2.82%+1.41%-14.77%-17.47% 1.64B
+2.16%+0.31%-30.10%-31.98% 1.63B
Average +1.98%+1.24%-6.16%-0.03% 20.51B
Weighted average by Cap. +0.46%-2.68%-5.09%+20.13%

Financials

2026 *2027 *
Net sales 27.29B 23.61B 22.05B 20.22B 38.04B 2,597B 38.64B 259B 102B 1,302B 102B 100B 4,304B 29.68B 25.67B 23.98B 21.99B 41.37B 2,825B 42.03B 281B 110B 1,416B 111B 109B 4,681B
Net income 4.94B 4.27B 3.99B 3.66B 6.89B 470B 7B 46.83B 18.38B 236B 18.56B 18.15B 779B 5.75B 4.97B 4.64B 4.26B 8.01B 547B 8.14B 54.46B 21.37B 274B 21.58B 21.11B 906B
Net Debt 9.13B 7.89B 7.37B 6.76B 12.72B 868B 12.92B 86.48B 33.94B 435B 34.27B 33.52B 1,439B 5.89B 5.09B 4.76B 4.36B 8.21B 560B 8.34B 55.8B 21.9B 281B 22.11B 21.63B 929B
Logo Stryker Corporation
Stryker Corporation is one of the world's leaders in designing, manufacturing and marketing medical equipment and devices in the fields of medical surgery, neurotechnology and orthopaedics. Net sales break down by family of products as follows: - surgical equipment and neurotechnology products (62.3%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipment, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (37.7%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2025, the group had 55 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (75.7%), Europe/Middle East/Africa (12.7%), Asia/Pacific (8.6%) and other (3%).
Employees
56,000
Date Price Change Volume
07/08/26 292.30 +0.07% 276
06/08/26 €292.10 +1.85% 241
05/08/26 €286.80 -1.34% 341
04/08/26 €290.70 -0.07% 221
03/08/26 €290.90 +3.45% 135
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
337.43USD
Average target price
382.04USD
Spread / Average Target
+13.22%

Quarterly revenue - Rate of surprise